Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype.
about
Transglutaminase is a tumor cell and cancer stem cell survival factorTransglutaminase 2 overexpression induces depressive-like behavior and impaired TrkB signaling in miceTransglutaminase regulation of cell function.Novel 3-arylethynyl-substituted thieno[3,4-b]pyrazine derivatives as human transglutaminase 2 inhibitors.Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition.Testing for differentially expressed genetic pathways with single-subject N-of-1 data in the presence of inter-gene correlation.Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cellsPARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.Transglutaminase 2 in cancer.TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated AutophagyThe complex role of transglutaminase 2 in glioblastoma proliferation.Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography.Oxidative stress shapes breast cancer phenotype through chronic activation of ATM-dependent signaling.Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.Tissue transglutaminase 2 exerts a tumor-promoting role in hepatitis B virus-related hepatocellular carcinoma.Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.Distinct protein expression and activity of transglutaminases found in different epidermal tumors.Transglutaminase 2 is involved in amyloid-beta1-42-induced pro-inflammatory activation via AP1/JNK signalling pathways in THP-1 monocytes.Positive Feedback Regulation between Transglutaminase 2 and Toll-Like Receptor 4 Signaling in Hepatic Stellate Cells Correlates with Liver Fibrosis Post Schistosoma japonicum Infection.Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer.In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model.Transcriptomic response of breast cancer cells to anacardic acid.
P2860
Q26799862-4DAFBB56-CFE1-4965-9991-0E366A1006BDQ30841720-1DF3DCC4-015C-430C-B87B-988FE9D48E6FQ33707936-F048BD8A-A45D-4D05-B4C0-5FA57FB2C0C9Q35176934-B20FD1F7-7BE0-4717-986F-775570A23796Q35609259-38845CBC-C5A1-4B04-BFAC-63726CF2BB30Q36040355-40EEA596-9113-4D65-A447-A34F00E7E733Q36299744-5FB8AEE6-ACF5-4DC1-A145-A9ED4B9E2516Q36383597-1311C067-C392-4398-A892-274EDADCD0C7Q36916421-3CC1C6B8-4462-40FD-AA95-90DB9B8729BBQ37548974-A6970C4D-7E39-408F-B639-19E52B0A510DQ37665592-40EE9453-95F1-43DE-A411-94904A3496F6Q38648421-3A2FE676-E387-4D38-8867-F5C52506AF06Q38734433-547FD15E-3246-49E8-B365-163AD0C94ED4Q38824727-3BE1C604-B110-4862-A6F7-B0B6F3416910Q38886629-6AAB6678-F3A9-4E75-84A1-22B5E78A5832Q38888783-799CF49F-899D-43F8-9841-E4330930FB9BQ38937553-A82C0E53-31FF-4B51-A4A1-7E11F91E5478Q39029196-11B1E234-8E97-4DED-BCEA-F4D7EC0089AAQ40484496-A0833342-C43A-410E-A16C-76EFB639AC86Q40963808-35952372-925E-4BB9-A884-13A2E97EC0F3Q42457743-5BEF0A8E-01ED-4406-807D-683FAD464BE6Q46457397-6A959240-0D72-43E4-8CB3-0DDCE8B19FD0Q47432711-6E65DAA9-5E50-47AC-8B58-A4679494EB36Q50893711-99EC1532-893A-458B-A670-9BAF188EBDC8Q55030374-610D37CE-7F4C-4E76-9367-007E6DD5DBF6Q55061507-AE6CFA62-05CD-4B09-BC1F-DD82F00CFC40
P2860
Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype.
@en
type
label
Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype.
@en
prefLabel
Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype.
@en
P2860
P1476
Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype.
@en
P2093
Kevin D Brown
P2860
P2888
P304
P356
10.1007/S10549-012-2351-7
P407
P577
2012-12-08T00:00:00Z
P6179
1034629488